BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sanchez-Mata A, Gonzalez-Muñoz E. Understanding menstrual blood-derived stromal/stem cells: Definition and properties. Are we rushing into their therapeutic applications? iScience 2021;24:103501. [PMID: 34917895 DOI: 10.1016/j.isci.2021.103501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Cordeiro MR, Carvalhos CA, Figueiredo-Dias M. The Emerging Role of Menstrual-Blood-Derived Stem Cells in Endometriosis. Biomedicines 2022;11. [PMID: 36672546 DOI: 10.3390/biomedicines11010039] [Reference Citation Analysis]
2 Cen J, Zhang Y, Bai Y, Ma S, Zhang C, Jin L, Duan S, Du Y, Guo Y. Research progress of stem cell therapy for endometrial injury. Mater Today Bio 2022;16:100389. [PMID: 36033375 DOI: 10.1016/j.mtbio.2022.100389] [Reference Citation Analysis]
3 Cristina Russu M. A New Cell Stem Concept for Pelvic Floor Disorders Prevention and Treatment. Endometrial Mesenchymal Stem Cells. Stem Cell Research [Working Title] 2022. [DOI: 10.5772/intechopen.108010] [Reference Citation Analysis]
4 Wu M, Guo Y, Wei S, Xue L, Tang W, Chen D, Xiong J, Huang Y, Fu F, Wu C, Chen Y, Zhou S, Zhang J, Li Y, Wang W, Dai J, Wang S. Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging. J Nanobiotechnology 2022;20:374. [PMID: 35953871 DOI: 10.1186/s12951-022-01566-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Fathi-Kazerooni M, Fattah-Ghazi S, Darzi M, Makarem J, Nasiri R, Salahshour F, Dehghan-Manshadi SA, Kazemnejad S. Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II. Stem Cell Res Ther 2022;13:96. [PMID: 35255966 DOI: 10.1186/s13287-022-02771-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]